Wolff Wiese Magana’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.6K | Buy |
704
+44
| +7% | +$2.04K | 0.02% | 239 |
|
|
2025
Q1 | $40.3K | Buy |
660
+50
| +8% | +$3.05K | 0.03% | 210 |
|
|
2024
Q4 | $34.5K | Sell |
610
-250
| -29% | -$14.1K | 0.02% | 232 |
|
|
2024
Q3 | $44.5K | Sell |
860
-36
| -4% | -$1.86K | 0.03% | 199 |
|
|
2024
Q2 | $37.2K | Sell |
896
-97
| -10% | -$4.03K | 0.03% | 188 |
|
|
2024
Q1 | $53.9K | Sell |
993
-127
| -11% | -$6.89K | 0.05% | 138 |
|
|
2023
Q4 | $57.5K | Sell |
1,120
-40
| -3% | -$2.05K | 0.05% | 131 |
|
|
2023
Q3 | $67.3K | Sell |
1,160
-7
| -0.6% | -$406 | 0.05% | 163 |
|
|
2023
Q2 | $74.6K | Buy |
1,167
+30
| +3% | +$1.92K | 0.06% | 157 |
|
|
2023
Q1 | $78.8K | Sell |
1,137
-113
| -9% | -$7.83K | 0.06% | 150 |
|
|
2022
Q4 | $89.9K | Sell |
1,250
-16
| -1% | -$1.15K | 0.08% | 142 |
|
|
2022
Q3 | $90K | Sell |
1,266
-78
| -6% | -$5.55K | 0.07% | 177 |
|
|
2022
Q2 | $104K | Sell |
1,344
-38,838
| -97% | -$3.01M | 0.08% | 170 |
|
|
2022
Q1 | $2.93M | Buy |
40,182
+211
| +0.5% | +$15.4K | 1.97% | 6 |
|
|
2021
Q4 | $2.49M | Buy |
39,971
+3,102
| +8% | +$193K | 1.61% | 12 |
|
|
2021
Q3 | $2.18M | Buy |
36,869
+6,735
| +22% | +$398K | 1.54% | 15 |
|
|
2021
Q2 | $2.01M | Sell |
30,134
-327
| -1% | -$21.8K | 1.44% | 14 |
|
|
2021
Q1 | $1.92M | Buy |
30,461
+1,876
| +7% | +$118K | 1.5% | 14 |
|
|
2020
Q4 | $1.77M | Buy |
+28,585
| New | +$1.77M | 1.5% | 12 |
|